MYZAP promotes angiogenesis by targeting RND1 after myocardial infarction
Lina Xuan, Guangze Wang, Xiufang Li, Shengjie Wang, Yuman Gao, Jingheng Wang, Hui Zhang, Shuo Zhuang, Huishan Luo, Jianjun Guo, Mingyu Zhang, Xingmei Yang, Hailong Zhang, Qingqing Zhang, Yiyang Qiao, Kai Kang, Ying Zhang, Lihua Sun · 2026
Read MYZAP promotes angiogenesis by targeting RND1 after myocardial infarction by Lina Xuan, Guangze Wang, Xiufang Li, Shengjie Wang, Yuman Gao, Jingheng Wang, Hui Zhang, Shuo Zhuang, Huishan Luo, Jianjun Guo, Mingyu Zhang, Xingmei Yang, Hailong Zhang, Qingqing Zhang, Yiyang Qiao, Kai Kang, Ying Zhang, Lihua Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13581988.txt.
Description
Lina Xuan and co-authors show that MYZAP promotes new vessel growth after heart attack by targeting RND1 in a 2026 study. Heart attack stays a top killer, and regrowing vessels in damaged heart muscle could aid repair.
MYZAP levels fell in heart attack tissue. Raising MYZAP only in vessel lining cells improved heart function and vessel growth in mice. Cell tests showed MYZAP restores growth, movement, and tube forming that low oxygen had cut. Its effect runs through direct binding to RND1 and a growth signal pathway, with an enzyme tagging RND1 for removal. Blocking the partner reversed the gain. The work names a fresh repair target.
Catalog record
| CREATOR | Lina Xuan, Guangze Wang, Xiufang Li, Shengjie Wang, Yuman Gao, Jingheng Wang, Hui Zhang, Shuo Zhuang, Huishan Luo, Jianjun Guo, Mingyu Zhang, Xingmei Yang, Hailong Zhang, Qingqing Zhang, Yiyang Qiao, Kai Kang, Ying Zhang, Lihua Sun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 98 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |